Cargando…
Is Cenobamate the Breakthrough We Have Been Wishing for?
Close to one-third of patients with epilepsies are refractory to current anti-seizure medications; however, trials with cenobamate suggest effectiveness in such patients with focal onset seizures. We searched for data published or otherwise reported on cenobamate and outlined these here. Despite bei...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431677/ https://www.ncbi.nlm.nih.gov/pubmed/34502246 http://dx.doi.org/10.3390/ijms22179339 |